{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:58:08Z","timestamp":1791413888199,"version":"4.3.3"},"reference-count":58,"publisher":"JMIR Publications Inc.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JMIR Diabetes"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec sec-type=\"background\">\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Continuous glucose monitors (CGM) reduce the burden of glycemic monitoring and improve glycemic control, quality of life, and decreased health care use. Despite expanded insurance coverage and adoption, barriers remain, especially in primary care. Existing research largely evaluates specific populations or interventions, leaving limited insight into the broader primary care experience.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"objective\">\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>This study aims to examine the experiences of adults with type 2 diabetes mellitus (T2DM) using CGM in primary care, guided by the Health Belief Model and Technology Acceptance Model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"methods\">\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>This qualitative study included in-person semistructured sessions (interviews or a focus group), surveys, and electronic health record data. Participants were recruited from 3 urban primary care (internal medicine and internal medicine-pediatrics) clinics affiliated with a large academic health system in Southwest Ohio, United States, with high rates of public insurance (Medicare or Medicaid). Eligible participants were adults (\u226518 y) with T2DM and a CGM prescription. Data were analyzed using theme generation guided by directed content analysis in MAXQDA (VERBI Software GmbH) with codes derived from Health Belief Model and Technology Acceptance Model constructs. Survey data were used to triangulate to enhance validity.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"results\">\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Overall, 16 participants (interviews: n=12; 1 focus group: n=4) were recruited for the study with a mean age of 56.9 (SD 10.5) years. In total, 69% (11\/16) identified as Black, 100% (16\/16) as Non-Hispanic, and 69% (11\/16) as female, and 94% (15\/16) used public insurance. Six themes emerged: disease susceptibility, disease severity, influential drivers, perceived ease of use, perceived usefulness, and attitude toward using CGM. All participants found CGM helpful and would recommend it to others. While affirming numerous barriers well-described in other populations, this study uniquely describes the burden of comorbidities, the trust in CGM data compared to glucometer-based monitoring, and the reliance on receivers to use CGM technology in this patient population.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec sec-type=\"conclusions\">\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>CGM is valued by adults with T2DM in primary care, yet barriers remain. Tailored support for initiation, troubleshooting, and education (especially alarm management and data interpretation) is needed. These insights can inform scalable strategies to enhance CGM use and experience in primary care.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2196\/73446","type":"journal-article","created":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T22:12:31Z","timestamp":1767132751000},"page":"e73446-e73446","source":"Crossref","is-referenced-by-count":3,"title":["Continuous Glucose Monitors Among Adults With Type 2 Diabetes Mellitus in the Primary Care Setting: Qualitative Study Informed by Technology Acceptance Model and Health Belief Model"],"prefix":"10.2196","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2584-1039","authenticated-orcid":false,"given":"Michelle I","family":"Knopp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3954-625X","authenticated-orcid":false,"given":"Ann Marie","family":"Castleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7567-8946","authenticated-orcid":false,"given":"Anna","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-1395-6100","authenticated-orcid":false,"given":"Jamarin","family":"Belger-Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7675-6902","authenticated-orcid":false,"given":"Mercedes","family":"Falciglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-0011-3100","authenticated-orcid":false,"given":"Aleona","family":"Zuzek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4297-9221","authenticated-orcid":false,"given":"Eneida","family":"Mendonca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1010","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"issue":"3","key":"R1","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1177\/1932296819899394","article-title":"Continuous glucose monitoring devices: past, present, and future focus on the history and evolution of technological innovation","volume":"15","author":"Didyuk","journal-title":"J Diabetes Sci Technol"},{"issue":"2","key":"R2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1177\/193229681000400225","article-title":"Self-monitoring of blood glucose: practical aspects","volume":"4","author":"Kirk","journal-title":"J Diabetes Sci Technol"},{"issue":"5","key":"R3","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1007\/s00125-024-06107-6","article-title":"Continuous glucose monitoring in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"67","author":"Jancev","journal-title":"Diabetologia"},{"issue":"10","key":"R4","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00125-024-06203-7","article-title":"The use of technology in type 2 diabetes and prediabetes: a narrative review","volume":"67","author":"Liarakos","journal-title":"Diabetologia"},{"issue":"2","key":"R5","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.pcd.2020.10.013","article-title":"Utilizing continuous glucose monitoring in primary care practice: what the numbers mean","volume":"15","author":"Edelman","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"R6","doi-asserted-by":"publisher","first-page":"15","DOI":"10.18553\/jmcp.2024.24255","article-title":"Initiating continuous glucose monitoring is associated with improvements in glycemic control and reduced health care resource utilization for people with diabetes in a large US-insured population: a real-world evidence study","volume":"31","author":"Norman","journal-title":"J Manag Care Spec Pharm"},{"issue":"1","key":"R7","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s00125-024-06289-z","article-title":"Intermittently scanned continuous glucose monitoring compared with blood glucose monitoring is associated with lower HbA and a reduced risk of hospitalisation for diabetes-related complications in adults with type 2 diabetes on insulin therapies","volume":"68","author":"Nathanson","journal-title":"Diabetologia"},{"issue":"12","key":"R8","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1089\/dia.2024.0171","article-title":"Reduced rate of hospitalizations for acute diabetes events before and after FreeStyle Libre\u00ae system initiation in some people with type 2 diabetes on insulin-secretagogue oral drug therapy without insulin in France","volume":"26","author":"Riveline","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"R9","doi-asserted-by":"publisher","first-page":"2299","DOI":"10.1007\/s12325-024-02851-8","article-title":"Reduction in diabetes-related hospitalizations and medical costs after Dexcom G6 continuous glucose monitor initiation in people with type 2 diabetes using intensive insulin therapy","volume":"41","author":"Hannah","journal-title":"Adv Ther"},{"issue":"7","key":"R10","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1089\/dia.2021.0525","article-title":"Association between real-time continuous glucose monitor use and diabetes-related medical costs for patients with type 2 diabetes","volume":"24","author":"Norman","journal-title":"Diabetes Technol Ther"},{"key":"R11","unstructured":"Magliano DJ Boyko EJ . IDF Diabetes Atlas. 10th ed. International Diabetes Federation; 2022. ISBN: 978-2-930229-98-0"},{"issue":"5","key":"R12","doi-asserted-by":"publisher","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the U.S. in 2017","volume":"41","author":"American Diabetes Association","journal-title":"Diabetes Care"},{"issue":"11","key":"R13","doi-asserted-by":"publisher","first-page":"1508","DOI":"10.1111\/dme.13448","article-title":"The prevalence of diabetes-specific emotional distress in people with Type 2 diabetes: a systematic review and meta-analysis","volume":"34","author":"Perrin","journal-title":"Diabet Med"},{"issue":"9","key":"R14","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae134","article-title":"The arduous path toward equitable access to endocrinology care","volume":"8","author":"Romeo","journal-title":"J Endocr Soc"},{"issue":"11","key":"R15","doi-asserted-by":"publisher","first-page":"2546","DOI":"10.1007\/s11606-023-08222-3","article-title":"Rates and correlates of uptake of continuous glucose monitors among adults with type 2 diabetes in primary care and endocrinology settings","volume":"38","author":"Mayberry","journal-title":"J Gen Intern Med"},{"issue":"8","key":"R16","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1080\/00325481.2022.2110507","article-title":"Stepwise approach to continuous glucose monitoring interpretation for internists and family physicians","volume":"134","author":"Szmuilowicz","journal-title":"Postgrad Med"},{"issue":"4 Suppl","key":"R17","doi-asserted-by":"publisher","first-page":"S76","DOI":"10.37765\/ajmc.2022.89215","article-title":"Addressing healthcare disparities and managed care considerations with continuous glucose monitoring","volume":"28","author":"McAdam-Marx","journal-title":"Am J Manag Care"},{"issue":"3","key":"R18","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1089\/dia.2022.0418","article-title":"Impact of expanding access to continuous glucose monitoring systems among insulin users with type 1 or type 2 diabetes","volume":"25","author":"Pathak","journal-title":"Diabetes Technol Ther"},{"issue":"S1","key":"R19","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1089\/dia.2021.0007","article-title":"Type 2 diabetes and the use of real-time continuous glucose monitoring","volume":"23","author":"Jackson","journal-title":"Diabetes Technol Ther"},{"key":"R20","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2023.1182260","article-title":"Short-term use of CGM in youth onset type 2 diabetes is associated with behavioral modifications","volume":"14","author":"Manfredo","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"R21","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1177\/26350106231205030","article-title":"Barriers and facilitators to uptake of continuous glucose monitoring for management of type 2 diabetes mellitus in youth","volume":"49","author":"Peyyety","journal-title":"Sci Diabetes Self Manag Care"},{"issue":"4","key":"R22","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1177\/19322968221139873","article-title":"Real-time continuous glucose monitoring in adolescents and young adults with type 2 diabetes can improve quality of life","volume":"18","author":"Chesser","journal-title":"J Diabetes Sci Technol"},{"issue":"4","key":"R23","doi-asserted-by":"publisher","first-page":"452","DOI":"10.2337\/ds21-0067","article-title":"Continuous glucose monitoring plus an online peer support community reinforces healthy behaviors in hispanic adults with type 2 diabetes","volume":"35","author":"Litchman","journal-title":"Diabetes Spectr"},{"issue":"3","key":"R24","doi-asserted-by":"publisher","DOI":"10.2196\/12936","article-title":"An evaluation of digital health tools for diabetes self-management in hispanic adults: exploratory study","volume":"4","author":"Yingling","journal-title":"JMIR Diabetes"},{"issue":"8","key":"R25","doi-asserted-by":"publisher","DOI":"10.1210\/jendso\/bvae125","article-title":"Continuous glucose monitor: reclaiming type 2 diabetes self-efficacy and mitigating disparities","volume":"8","author":"Ni","journal-title":"J Endocr Soc"},{"issue":"4","key":"R26","doi-asserted-by":"publisher","DOI":"10.2196\/21551","article-title":"Continuous glucose monitoring with low-carbohydrate diet coaching in adults with prediabetes: mixed methods pilot study","volume":"5","author":"Yost","journal-title":"JMIR Diabetes"},{"issue":"1\u201312","key":"R27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/07435800.2025.2577643","article-title":"Overcoming underutilization of continuous glucose monitoring devices with diabetes among disparate populations","volume":"24","author":"Nasser","journal-title":"Endocr Res"},{"issue":"3","key":"R28","doi-asserted-by":"publisher","first-page":"40338639","DOI":"10.1093\/intqhc\/mzaf046","article-title":"Continuous glucose monitoring in type 2 diabetes: a systematic review of barriers and opportunities for care improvement","volume":"37","author":"Barchiesi","journal-title":"Int J Qual Health Care"},{"key":"R29","unstructured":"Alyafei A Easton-Carr R . The health belief model of behavior change. In: StatPearls. StatPearls Publishing; 2025. [Medline: 39163427]"},{"issue":"1","key":"R30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/109019818401100101","article-title":"The health belief model: a decade later","volume":"11","author":"Janz","journal-title":"Health Educ Q"},{"key":"R31","unstructured":"Davis F . User Acceptance of Information Systems: the Technology \u0410cceptance Model (Working Paper #529). University of Michigan; 1987. URL: https:\/\/quod.lib.umich.edu\/b\/busadwp\/images\/b\/1\/4\/b1409190.0001.001.pdf [Accessed 17-12-2025]"},{"issue":"2","key":"R32","doi-asserted-by":"publisher","first-page":"419","DOI":"10.6007\/IJARPED\/v11-i2\/12938","article-title":"The interpretivist research paradigm: a subjective notion of a social context","volume":"11","author":"Pervin","journal-title":"IJARPED"},{"issue":"6","key":"R33","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1093\/intqhc\/mzm042","article-title":"Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups","volume":"19","author":"Tong","journal-title":"Int J Qual Health Care"},{"issue":"4","key":"R34","doi-asserted-by":"publisher","first-page":"1893","DOI":"10.1007\/s11135-017-0574-8","article-title":"Saturation in qualitative research: exploring its conceptualization and operationalization","volume":"52","author":"Saunders","journal-title":"Qual Quant"},{"issue":"2","key":"R35","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","journal-title":"J Biomed Inform"},{"key":"R36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners","volume":"95","author":"Harris","journal-title":"J Biomed Inform"},{"key":"R37","unstructured":"MAXQDA. 2022. URL: https:\/\/www.maxqda.com\/ [Accessed 16-12-2025]"},{"key":"R38","unstructured":"The SAGE Handbook of Qualitative Research. 5th ed. Sage Books; 2018. ISBN: 1483349802"},{"key":"R39","unstructured":"Miles M Huberman A Saldana J . Qualitive Data Analysis: A Methods Sourcebook. 3rd ed. Sage; 2014. URL: https:\/\/ia803100.us.archive.org\/0\/items\/spradleyanalisisdatakualitatifmodeletnografi\/Matthew_Miles%2C_Michael_Hberman%2C_Johnny_Sdana-Qualitative_Data_Analysis__A_Methods_Sourcebook-Sage_%282014%29%5B1%5D.pdf [Accessed 16-12-2025]"},{"issue":"9","key":"R40","doi-asserted-by":"publisher","first-page":"1277","DOI":"10.1177\/1049732305276687","article-title":"Three approaches to qualitative content analysis","volume":"15","author":"Hsieh","journal-title":"Qual Health Res"},{"issue":"1","key":"R41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/14780887.2022.2066036","article-title":"Facilitation strategies for conducting focus groups attending to issues of power","volume":"20","author":"Kornbluh","journal-title":"Qual Res Psychol"},{"issue":"3","key":"R42","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2337\/cd23-0077","article-title":"Detection and intervention: use of continuous glucose monitoring in the early stages of type 2 diabetes","volume":"42","author":"Miller","journal-title":"Clin Diabetes"},{"issue":"4","key":"R43","doi-asserted-by":"publisher","first-page":"671","DOI":"10.3122\/jabfm.2024.240049R1","article-title":"Clinician-reported barriers and needs for implementation of continuous glucose monitoring","volume":"37","author":"Hall","journal-title":"J Am Board Fam Med"},{"issue":"10","key":"R44","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1089\/dia.2023.0268","article-title":"Coverage for continuous glucose monitoring for individuals with type 2 diabetes treated with nonintensive therapies: an evidence-based approach to policymaking","volume":"25","author":"Aleppo","journal-title":"Diabetes Technol Ther"},{"issue":"4","key":"R45","doi-asserted-by":"publisher","first-page":"974","DOI":"10.1177\/19322968221144052","article-title":"Increase access, reduce disparities: recommendations for modifying Medicaid CGM coverage eligibility criteria","volume":"18","author":"Galindo","journal-title":"J Diabetes Sci Technol"},{"key":"R46","doi-asserted-by":"publisher","DOI":"10.2196\/58832","article-title":"Exploring the impact of device sourcing on real-world adherence and cost implications of continuous glucose monitoring in patients with diabetes: retrospective claims analysis","volume":"9","author":"Allaire","journal-title":"JMIR Diabetes"},{"issue":"1","key":"R47","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1177\/0145721709352010","article-title":"Practical aspects of real-time continuous glucose monitors: the experience of the Yale Children\u2019s Diabetes Program","volume":"36","author":"Ives","journal-title":"Diabetes Educ"},{"issue":"1","key":"R48","doi-asserted-by":"publisher","first-page":"e7","DOI":"10.1016\/j.clinthera.2023.10.005","article-title":"Partnering for better health: using continuous glucose monitoring and clinical pharmacist collaboration to improve glycemic control in underserved patients with type 2 diabetes","volume":"46","author":"Powell","journal-title":"Clin Ther"},{"key":"R49","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2021.109048","article-title":"Help when you need it: perspectives of adults with T1D on the support and training they would have wanted when starting CGM","volume":"180","author":"Tanenbaum","journal-title":"Diabetes Res Clin Pract"},{"issue":"3","key":"R50","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1177\/193229681300700324","article-title":"\u201cTurn it off!\u201d: diabetes device alarm fatigue considerations for the present and the future","volume":"7","author":"Shivers","journal-title":"J Diabetes Sci Technol"},{"issue":"12","key":"R51","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1089\/dia.2024.0197","article-title":"Long-term improvements in glycemic control with Dexcom CGM use in adults with noninsulin-treated type 2 diabetes","volume":"26","author":"Layne","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"R52","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1089\/dia.2023.0333","article-title":"More frequent use of glucose alarms is associated with continuous glucose monitoring-specific diabetes education: findings from the dia\u00b7link diabetes panel","volume":"26","author":"Ehrmann","journal-title":"Diabetes Technol Ther"},{"issue":"19-20","key":"R53","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.1111\/jocn.14330","article-title":"Challenges in everyday life among recently diagnosed and more experienced adults with type 2 diabetes: a multistage focus group study","volume":"27","author":"Gardsten","journal-title":"J Clin Nurs"},{"issue":"10","key":"R54","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1089\/dia.2023.0612","article-title":"The potential impact of continuous glucose monitoring use on diabetes-related attitudes and behaviors in adults with type 2 diabetes: a qualitative investigation of the patient experience","volume":"26","author":"Clark","journal-title":"Diabetes Technol Ther"},{"issue":"6","key":"R55","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1089\/dia.2022.0011","article-title":"Accuracy and safety of Dexcom G7 continuous glucose monitoring in adults with diabetes","volume":"24","author":"Garg","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"R56","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1177\/19322968211058148","article-title":"The need for data standards and implementation policies to integrate CGM Data into the electronic health record","volume":"17","author":"Espinoza","journal-title":"J Diabetes Sci Technol"},{"key":"R57","doi-asserted-by":"publisher","DOI":"10.1177\/15209156251395034","article-title":"Multivendor continuous glucose monitor integration into the electronic health record: real-world experience of an academic pediatric endocrinology clinic","author":"Knopp","journal-title":"Diabetes Technol Ther"},{"issue":"S3","key":"R58","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.1089\/dia.2023.0057","article-title":"Continuous glucose monitoring impact and implications of real-world evidence: past, present, and future","volume":"25","author":"Gavin","journal-title":"Diabetes Technol Ther"}],"container-title":["JMIR Diabetes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/diabetes.jmir.org\/2025\/1\/e73446","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T18:04:10Z","timestamp":1782842650000},"score":1,"resource":{"primary":{"URL":"https:\/\/diabetes.jmir.org\/2025\/1\/e73446"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":58,"URL":"https:\/\/doi.org\/10.2196\/73446","relation":{},"ISSN":["2371-4379"],"issn-type":[{"value":"2371-4379","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,30]]},"article-number":"v10i3e73446"}}